Stay updated on Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for cabozantinib with androgen ablation in metastatic prostate cancer is now displayed, with study details such as eligibility criteria, treatment plan, outcome measures, and a study protocol document. Previously, the page showed a 403 Forbidden error.
    Difference
    48%
    Check dated 2026-11-10T14:41:00.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:49:26.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T16:42:21.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T16:30:53.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with an added 403 HTML header and a Home link. This change replaces the previously visible study-record content and removes institution-specific references.
    Difference
    18%
    Check dated 2026-09-22T20:48:38.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.7.0 from v3.6.6, indicating a page version upgrade. This change is limited to the site’s versioning text and does not affect study details or user actions.
    Difference
    0.1%
    Check dated 2026-09-15T21:02:21.000Z thumbnail image

Stay in the know with updates to Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.